Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

Portmag Launches Portable Charger ‘Powerbank,’ Steps Up Global Market Expansion

SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ -- Portmag, a charging accessories manufacturer, has launched its private brand (PB) portable charger, Powerbank, accelerating its...

UTI Investments Partners with FTSE Russell to Transition its Sovereign Bond ETF Benchmark

SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- UTI Investments announced that its Sovereign Bond ETF (Bloomberg Ticker: UIGB NA Equity) offered under a Restricted Scheme...

Whalet Signs Agreement with OCBC to Drive Cross-Border Financial Innovation

SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- Whalet, a leading payment provider specializing in cross-border financial services, has inked an agreement with OCBC, Southeast Asia's...